12th Aug 2024 Plain language summary of the monarchE study: Abemaciclib with endocrine therapy for HR+, HER2-, node-positive and high-risk early breast cancer
2nd Nov 2023 A plain language summary of the PALOMA-2 and PALOMA-3 studies: the effects of adding palbociclib to endocrine therapy to treat advanced breast cancer
